Anti-MAPT Neutralizing Antibody (V3S-0723-FY234) (CAT#: V3S-0723-FY234)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description Humanized DC8E8 RHD/RKA is a recombinant human antibody that identifies Human MAPT. It also reacts with mouse. The humanized antibody, DC8E8, specifically target human tau and can differentiate between normal (healthy) and pathological (disease-associated) tau. Humanized DC8E8 RHD/RKA exhibiting an EC50 of 0.0285 ug/mL.
Clonality Monoclonal
Host Species Human
Target Species Human, Mouse
Isotype IgG1, kappa

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application Block; IHC
Application Notes Humanized DC8E8 RHD/RKA has an EC50 of 0.0285 ug/mL.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target MAPT
Alternative Name TAU; MSTD; PPND; DDPAC; MAPTL; MTBT1; MTBT2; FTDP-17; PPP1R103
Gene ID 4137
UniProt P10636
Research Area Neuroscience; Signal Pathway
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry